Articles On Telix Pharmaceuticals (ASX:TLX)

S&P/ASX 200 Index (ASX: XJO) blue-chip shares can make some of the most appealing investments, due to the combination of their strong competitive position and long growth runway ahead. The two companies I'm going to highlight have bo...

Yesterday afternoon, Telix Pharmaceuticals Ltd (ASX: TLX) reported US$206 million in unaudited group revenue for Q3 2025, up 53% year-over-year, and upgraded its FY 2025 revenue guidance to US$800–820 million. What did Telix Pharmaceutica...

On Tuesday, the S&P/ASX 200 Index (ASX: XJO) fought hard and carved out a small gain. The benchmark index rose 0.2% to 8,899.4 points. Will the market be able to build on this on Wednesday? Here are five things to watch: ASX 200 expec...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Oct. 14, 2025 /PRNewswire/ – Telix Pharmac...

A surge in September-quarter earnings has led Melbourne-based Telix Pharmaceuticals’ (ASX: TLX) to upgrade its full-year revenue forecast to a high of US$820 million ($1.26 billion) as the company’s growth was driven by the launch of new pr...

With the average dividend yield from the S&P/ASX 200 Index (ASX: XJO) dropping below 3.5% this year, this exchange-traded fund (ETF) certainly catches the eye with its 9% trailing gross distribution yield. According to Betashares, t...

Highlights Gold and critical minerals lead midday momentum across large, mid, and small names Defensive infrastructure and logistics display steady relative strength Technology, healthcare, and consumer brands face pressure...

For long-term investors, finding quality Australian stocks that can grow their earnings year after year is the ultimate goal. These are the kinds of businesses you can buy, tuck away, and confidently hold through market ups and downs. They...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin This week's In Brief presents two stocks which have fallen due to extraneous factors...

Telix Pharmaceuticals Ltd (ASX: TLX) is one of the ASX shares with the most buy recommendations right now. According to the recommendations collated by Commsec, the business is currently rated as a buy by 15 different analysts. It's r...

Highlights Lithium and critical mineral stocks gain momentum Consumer and tech sectors experience weakness Broader sentiment sways amid shifting rate outlook Australian AGM season sparks interest as top ASX Ordinaries...

The Australian share market may be hovering near record highs, but that doesn't mean opportunities have disappeared. In fact, every market cycle creates its own pockets of value, sometimes hiding in plain sight. While parts of the ASX are l...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin A summary of the highlights from Broker Call Extra updates throughout the week past....

It was another bumpy session for ASX shares and the S&P/ASX 200 Index (ASX: XJO) this Wednesday. After narrowly missing out on a rise yesterday, investors were in for a similar experience today, with...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Sept. 30, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited...

ASX up 75 points to 8862.8 with 9 sectors higher Healthcare, banks and gold stocks drive gains Energy, info tech languish in the red   ASX pushes higher alongside spot gold The ASX 200 hummed higher throughout the day, closing out up 0.86...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

Australian shares are heading into Week 40 in the green, according to ASX 200 futures, though whether that +0.4% gain holds through the trading week is up in the air, considering we have a Reserve Bank cut call looming. Listen to the Hot...

ASX crawls up just 0.17pc with 7 sectors lower Healthcare sharply lower as Trump threatens tariffs on pharmaceuticals Strength in resources and banks outweighs greater market losses   Markets take stock as tariffs fire back up After a pol...

Highlights US pharma tariffs weigh on leading Australian healthcare stocks Silver outpaces gold in the commodities race Energy sector advances on European project updates Global tariffs weighed on healthcare names like...

It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these...

It has been a tough finish to the week for the healthcare sector. In afternoon trade, the S&P/ASX 200 Health Care index is down 1.4%. This compares unfavourably to a small gain by the broader ASX 200 index. Here's the current state of p...

It has been a difficult year for owners of Telix Pharmaceuticals Ltd (ASX: TLX) shares. A series of disappointing announcements has put significant pressure on the radiopharmaceuticals company's shares. However, Bell Potter notes that there...

On Thursday, the S&P/ASX 200 Index (ASX: XJO) had a mildly positive session and finished the day a fraction higher. The benchmark index rose 0.1% to 8,773 points. Will the market be able to bounce back from this on Friday and end the...

Highlights Several ASX-listed companies hit fresh yearly lows after earnings results. Weak outlooks and missed targets dominated across diverse sectors. Healthcare and consumer names emerged as focal points of investor conce...

Highlights Multiple well-known companies hit fresh one-year lows. Healthcare, consumer, and industrials sectors faced broad challenges. Missed earnings remain a recurring theme across these declines. Multiple ASX-liste...

Many of Australia's top brokers have been busy adjusting their financial models and recommendations again. This has led to the release of a number of broker notes this week. Three ASX shares that brokers have named as buys this week are lis...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US markets took a breather with profit taking most apparent in technology stocks as...

2025 has been a tough year for Telix Pharmaceuticals Ltd (ASX: TLX) investors. Since the start of January, shares in the cancer diagnostics specialist have dropped by 31% to $16.38 per share at Tuesday's close. In comparison, the benc...

It was another strong session for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares this Tuesday. The ASX backed up yesterday's strong start to the trading week with another rise today. By the tim...

Highlights: Key updates from aerospace, defence, rare earths, and biotech sectors Strong momentum in manufacturing and services across Australia Multiple ASX-listed companies deliver significant market activity ASX ses...

What does it take to be the best service provider in your field? Four leaders in defence tech, healthtech, executive recruitment and water infrastructure give us a glimpse. Ahead of the 2026 EY Entrepreneur Of The Year™ program’s 25th annua...

The S&P/ASX 200 Index (ASX: XJO) is having a decent session on Tuesday. At the time of writing, the benchmark index is up 0.4% to 8,848.9 points. Four ASX shares that are rising more than most today are listed below. Here's why they ar...

S&P/ASX All Ordinaries Index (ASX: XAO) shares are 0.37% higher at 9,137.7 points on Tuesday. The ASX All Ords has risen 8% over the year to date, but many stocks have experienced much larger moves in opposite directions. On Th...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Flighty investors have caused share prices to fall in 2025, but MPC Markets' Mark Ga...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are racing higher on Tuesday morning. At the time of writing, the radiopharmaceuticals company's shares are up 22% to $18.32. This compares favourably to a 0.3% gain by the ASX 200 index in early...

Sometimes the best opportunities come when the market is looking the other way. Right now, a handful of promising ASX shares are trading well below their recent highs or flying under the radar altogether. For investors willing to act early,...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Sept. 23, 2025 /PRNewswire/ – IMRA Surgical, an Australian-...

Highlights Key ASX-listed companies marked fresh yearly highs and lows across diverse sectors. Gold miners, REITs, and financial firms dominated the high ranks. Healthcare and discretionary sectors showed weakness with multi...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

It was an upbeat end to the trading week this Friday, with the S&P/ASX 200 Index (ASX: XJO) bouncing back to close 0.32% higher. After a few days of negative sentiment, investors evidently decided to...

ASX pares back early gains to lift 0.32pc Healthcare, tech, utilities drive gains Resources sector drags as gold prices slip from highs ASX gets clean bill of health The ASX was looking a little healthier today, adding 0.32% or 28.3 poi...

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episode, host Tylah Tully looks into the share price increase of big gun radiopharmaceuticals company Telix Pharmaceuticals (ASX:TLX), which surge...

ASX heath sector fell 0.37% over past five days, while broader markets down 0.5% Telix finds way forward with the FDA on brain cancer imaging agent Pixclara Big Pharma to showcase Clever Culture Systems tech at major global conferences  ...

Highlights Healthcare Sector Faces Challenges: Companies like (ASX:CSL) are experiencing significant declines. Gold Stocks Show Resilience: (ASX:RSG), (ASX:EVN), and (ASX:RRL) demonstrate notable gains. Short Selling Activities o...

Pitt Street Research says Imagion is significantly undervalued and sits around 75-80% below target range of 12.3 to 14.9 cents per share Research house sees further upside if MagSense imaging agent tech progresses to commercialisation in a...

If you have $10,000 to invest in the ASX today, but don't know which stocks to choose, take a look at my two top picks for the week. NextDC Ltd (ASX: NXT) Outperformance of shares in the technology sector this week has helped to offs...

It was a day of relief for investors this Wednesday, as the S&P/ASX 200 Index (ASX: XJO) shook off the malaise that afflicted the markets earlier this week to push higher.  By the time trading wrapp...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. At the time of writing, the benchmark index is up 0.25% to 8,827.1 points. Four ASX shares that are rising more than most today are listed below....

History tells us that September can be a turbulent month for ASX 200 shares as the dust settles on earnings season results. On trend, the S&P/ASX 200 Index (ASX: XJO) has shed 1.4% already this month.  However, this can also be an...